tiprankstipranks
Savara price target raised to $16 from $7 at Piper Sandler
PremiumThe FlySavara price target raised to $16 from $7 at Piper Sandler
1M ago
A New Cause for Concern: CymaBay Therapeutics Inc Adds a New Corporate Activity and Growth Risk
PremiumCompany Announcements
A New Cause for Concern: CymaBay Therapeutics Inc Adds a New Corporate Activity and Growth Risk
1M ago
CymaBay reports Q4 EPS (35c), consensus (31c)
PremiumThe Fly
CymaBay reports Q4 EPS (35c), consensus (31c)
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
CymaBay downgraded to Market Perform from Outperform at LifeSci Capital
PremiumThe Fly
CymaBay downgraded to Market Perform from Outperform at LifeSci Capital
2M ago
CymaBay downgraded to Market Perform from Strong Buy at Raymond James
PremiumThe FlyCymaBay downgraded to Market Perform from Strong Buy at Raymond James
2M ago
CymaBay downgraded to Neutral from Buy at B. Riley
PremiumThe Fly
CymaBay downgraded to Neutral from Buy at B. Riley
2M ago
CymaBay downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe Fly
CymaBay downgraded to Neutral from Overweight at Cantor Fitzgerald
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100